Skip to content

Should treatment breaks be guided by CD4? Study suggests yes

South Africa: MCC back pedals on nevirapine for mums to be

HIV-positive Brazilian women find adherence hard

Tenofovir no more likely than d4T to cause kidney side-effects

Use drug holidays cautiously in NNRTI-treated patients

Starting HAART at higher CD4 cell counts means treatment can be safely stopped for longer

15% of patients who fail treatment with NRTI, NNRTIs and PIs die within 3 years

Adding ddI achieves fall in viral load in HAART patients with resistance

Abacavir leads to better CD4 increase than AZT when combined with 3TC and EFV